Ibex Medical Analytics的动态

ICYMI earlier this month we announced that Ibex received our first FDA 510(k) clearance! This milestone validates the safety and effectiveness of our #AIpowered solution and strengthens our commitment to delivering cutting-edge innovation to #pathologists. Through robust precision and clinical validation studies conducted during the FDA clearance process, Ibex Prostate Detect identified a 13% rate of missed cancers in patients initially diagnosed as benign. This underscores the critical role of our technology as a safety net for pathologists, ensuring patients receive an accurate cancer diagnosis. To learn more, visit the link in the comments. #AI #Pathology #ProstateCancer #Diagnostics #FDAClearance